Bortezomib
Common brands: Velcade, Maxidex, Hemady, Dexamethasone 1.5 Mg, Ozurdex
Top reporter: Takeda Pharmaceuticals America, Inc.
Proteasome Inhibitor [EPC]Corticosteroid [EPC]Thalidomide Analog [EPC]CD38-directed Cytolytic Antibody [EPC]Alkylating Drug [EPC]
87,536
Total Reports
36,870
Serious Reports
13,924
Death Reports
30
Reported Reactions
Death Report Ratio: High (15.91%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Bortezomib.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | PLASMA CELL MYELOMA | 8,975 | |
| 2 | NEUROPATHY PERIPHERAL | 6,318 | |
| 3 | OFF LABEL USE | 6,272 | |
| 4 | DIARRHOEA | 5,107 | |
| 5 | FATIGUE | 4,503 | |
| 6 | DEATH | 4,163 | |
| 7 | PNEUMONIA | 4,024 | |
| 8 | DRUG INEFFECTIVE | 3,675 | |
| 9 | THROMBOCYTOPENIA | 3,640 | |
| 10 | NAUSEA | 3,072 | |
| 11 | PYREXIA | 2,825 | |
| 12 | ANAEMIA | 2,681 | |
| 13 | NEUTROPENIA | 2,649 | |
| 14 | DISEASE PROGRESSION | 2,404 | |
| 15 | RASH | 2,397 | |
| 16 | ASTHENIA | 2,205 | |
| 17 | CONSTIPATION | 2,181 | |
| 18 | PLATELET COUNT DECREASED | 2,150 | |
| 19 | DYSPNOEA | 2,086 | |
| 20 | VOMITING | 1,796 | |
| 21 | SEPSIS | 1,775 | |
| 22 | INTENTIONAL PRODUCT USE ISSUE | 1,595 | |
| 23 | INFECTION | 1,591 | |
| 24 | DIZZINESS | 1,520 | |
| 25 | HYPOTENSION | 1,479 | |
| 26 | PRODUCT USE IN UNAPPROVED INDICATION | 1,432 | |
| 27 | DECREASED APPETITE | 1,415 | |
| 28 | FEBRILE NEUTROPENIA | 1,382 | |
| 29 | WHITE BLOOD CELL COUNT DECREASED | 1,371 | |
| 30 | PANCYTOPENIA | 1,362 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.